Citizens Maintains Market Outperform on Pharvaris, Lowers Price Target to $74
Pharvaris N.V.
Pharvaris N.V. PHVS | 0.00 |
Citizens analyst Jonathan Wolleben maintains Pharvaris (NASDAQ:
PHVS) with a Market Outperform and lowers the price target from $75 to $74.
